FEZ1 and Alzheimer disease: Interestingly, abnormal co-aggregates of FEZ1 and Kinesin-1 were described in the brains of mouse models of Alzheimer’s disease, suggesting a perturbation of FEZ1-mediated synaptic protein delivery (Butkevich et al., 2016).